SCHEMBL30813648

SCHEMBL30813648

COc1ccc(CNc2ncnc3c2c([Sn](C)(C)C)nn3C2CCN(C(=O)OC(C)(C)C)CC2)c(OC)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EPHX2 P34913 1/20 0.43
▸ CYP3A4 P08684 2/20 0.43
▸ STS P08842 1/20 0.41
▸ SRC P12931 2/20 0.41
▸ EGFR P00533 2/20 0.41
▸ ABL1 P00519 1/20 0.41
▸ ABL2 P42684 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ CYP2C9 P11712 1/20 0.40
▸ GPR119 Q8TDV5 2/20 0.40
▸ PDE9A O76083 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ NR3C1 P04150 2/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ RET P07949 1/20 0.39
▸ KDR P35968 1/20 0.39
▸ CTSD P07339 1/20 0.39
▸ CTSE P14091 1/20 0.39
▸ BACE1 P56817 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27217837 1.00 EPHX2 (0.43) EPHX2CYP3A4STSSRCEGFR
SCHEMBL30813475 0.93 RET (0.40) EPHX2CYP3A4SRCEGFRABL1
SCHEMBL27217814 0.93 RET (0.40) EPHX2CYP3A4SRCEGFRABL1
SCHEMBL27217885 0.92 BTK (0.45) EPHX2SRCEGFRABL1ABL2
SCHEMBL30813419 0.90 EPHX2 (0.44) EPHX2CYP3A4STSSRCEGFR
SCHEMBL27217888 0.87 CYP1A2 (0.45) CYP3A4MAPTCYP2C9PDE9AKMT2A
SCHEMBL27217936 0.85 CYP1A2 (0.42) CYP3A4EGFRMAPTCYP2C9PDE9A
SCHEMBL30813667 0.85 CYP1A2 (0.42) CYP3A4EGFRMAPTCYP2C9PDE9A
SCHEMBL30813465 0.84 RET (0.40) EPHX2CYP3A4SRCEGFRABL1
SCHEMBL30813513 0.83 CYP1A2 (0.43) CYP3A4MAPTCYP2C9PDE9AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024059200-A1 NEK7 INHIBITORS Halia Therapeutics, Inc. (US) 2024-03-21 — — WO disclosed
Send feedback